| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2984003 | The Journal of Thoracic and Cardiovascular Surgery | 2010 | 10 Pages |
Abstract
Combined vorinostat and bortezomib therapy significantly decreased esophageal cancer epithelial-mesenchymal transition. This combined therapeutic effect on esophageal cancer epithelial-mesenchymal transition was associated with upregulation of E-cadherin protein expression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Matthew D. MD, Yuan MD, PhD, Alykhan S. MD, Nicholas BS, David R. MD,